Cingulate Inc. CING
4.25 USD +0.01 (+0.18%)
Nov 6, 2026, 9:36 AM EST
4.25 Day range 4.25
3.16 52-week range 11.89
- YTD
- -2.13%
- 1 year
- +15.42%
News
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares rose 93.3% to $2.03 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. Scinai Immunotherapeutics (NASDAQ:SCNI)…
benzinga.com Roth Capital Reiterates Buy on Cingulate, Lowers Price Target to $9 Roth Capital analyst Boobalan Pachaiyappan reiterates Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $10 to $9.
benzinga.com Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $44 Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $52 to $44.
benzinga.com Cingulate Q2 EPS $(0.45) Beats $(0.63) Estimate Cingulate (NASDAQ:CING) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.63) by 28.57 percent. This is a 60.53 percent increase over losses of $(1.14)…
benzinga.com Cingulate Joins Russell 3000E Index Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of…
benzinga.com Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday Wall Street analysts change outlook on top names. B of A cuts CPB, UBS cuts AJG PT, B of A boosts ORCL PT, Needham raises APLD PT, Morgan Stanley raises AAPL PT, BTIG raises NRIX PT, GLJ Research…
benzinga.com Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analyst ratings page.
benzinga.com Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $52 Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $55 to $52.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com Cingulate Receives FDA Complete Response Letter For ADHD Treatment CTx-1301 Requesting Specific Information About Chemistry, Manufacturing, And Controls, Contains No Concerns Regarding Safety Or Efficacy The response identified specific Chemistry, Manufacturing and Controls (CMC) information requests and did not raise any current concerns regarding the clinical safety or efficacy of CTx-1301.…- benzinga.com HC Wainwright & Co. Reiterates Buy on Cingulate, Maintains $20 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cingulate (NASDAQ:CING) with a Buy and maintains $20 price target.
- benzinga.com Cingulate Q1 EPS $(0.95) Misses $(0.53) Estimate Cingulate (NASDAQ:CING) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.53) by 79.25 percent. This is a 10.38 percent increase over losses of $(1.06)…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
benzinga.com Amazon To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday Wall Street analysts changed outlook on top names. See all changes on Benzinga's analyst ratings page. Price targets and ratings altered for CING, WING, DEFT, FANG, PJT, DOCS, and AMZN.- benzinga.com Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $55 Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $58 to $55.
benzinga.com Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $14 Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $16 to $14.
benzinga.com What's Going On With Cingulate Stock Today? Cingulate slipped in premarket trading as investors weighed its wider quarterly loss against a fresh patent win and new funding to support its ADHD drug launch plans.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com Cingulate Q4 EPS $(0.84) Misses $(0.61) Estimate Cingulate (NASDAQ:CING) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.61) by 37.03 percent. This is a 500 percent decrease over losses of $(0.14)…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com Cingulate CEO Shane Schaffer Reinstated Following Legal Matter; Mr. Roberts To No Longer Serve As Executive Chairman Of The Board But Will Continue To Serve As Chairman Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed on August 14, 2025, the…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
- benzinga.com Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
benzinga.com Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - benzinga.com Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
benzinga.com Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.- benzinga.com Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents…
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.
- benzinga.com US Stocks Edge Higher On Last Trading Day Of 2023; Chicago PMI Falls In December U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 10 points on Friday. Following the market opening Friday, the Dow traded up 0.03% to 37,723.19 while the…
- benzinga.com Why Titan Pharmaceuticals Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket Shares of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose sharply in today’s pre-market trading session. Titan Pharmaceuticals said its Board of Directors has approved a 1-for-20 reverse stock split.…
- benzinga.com Gold Moves Lower; US Crude Stocks Decline Last Week U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90.…
- benzinga.com Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.
- benzinga.com Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. Bridgeline Digital posted a narrower-than-expected loss for its fourth…
- benzinga.com Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per…
benzinga.com Stocks That Hit 52-Week Lows On Monday Monday's session saw 175 companies set new 52-week lows.- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 56 companies set new 52-week lows.
- benzinga.com Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday.
- benzinga.com Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
- benzinga.com Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 153 companies set new 52-week lows.
- benzinga.com 93 Biggest Movers From Friday Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 348 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 313 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 89 companies hit new 52-week lows.